Minor hallucinations in Parkinson’s disease are associated with increased neurofilament plasma levels and reduced white-matter integrity in the inferior longitudinal fasciculus
Objective: To examine whether patients with Parkinson's disease (PD) and isolated minor hallucinations have increased plasma neurofilament light chain (NfL) levels and/or differences in white…Anxiety in Parkinson’s disease is associated with changes in the brain fear circuit
Objective: The aim of this study was to identify the anatomical and functional changes related to anxiety, especially in the “fear circuit”, by comparing PD…Neuroimaging of anxiety in Parkinson’s disease: a systematic review
Objective: The aim of this systematic review was 1) to identify the brain regions involved in anxiety in Parkinson's disease (PD) based on neuroimaging studies,…Impulse Control Disorders and Other Psychiatric Complications in a Series of Patients Treated Levodopa-Carbidopa Instestinal Gel
Objective: To determine the frequency of ICDs and other psychiatric complications in a serie of patients of the Movement Disorders Unit of our center, treated…Identification and Documentation of Delirium in Parkinson’s Disease
Objective: To establish documentation, assessment and diagnosis practices in the medical notes of inpatients with Parkinson’s disease (PD) and delirium. Background: Delirium is a neuropsychiatric…Improving Diagnosis and Treatment of Anxiety in Parkinson’s Disease: IDATA-PD Study Update
Objective: 1. To develop an inventory to assess Parkinson’s disease (PD) specific anxiety for person centred psychotherapy interventions. 2. To develop manualised cognitive behaviour therapy…Prevalence, Impact, and Suboptimal Treatment of Depression in the Fox Insight Cohort
Objective: Addressing unmet mental health needs in Parkinson’s disease (PD) requires delineating their scope and impact. This study evaluated (1) depressive symptom prevalence and treatment…Video-to-Home Cognitive-Behavioral Therapy for Veterans with Depression and Parkinson’s Disease: A Randomized Controlled Trial
Objective: For the nearly 100,000 veterans with Parkinson’s disease (PD) receiving Veterans Affairs (VA) health care, depression is prevalent, yet often undiagnosed or undertreated. This…Fear of progression in Parkinson’s disease: Preliminary results of a pilot cross-sectional study
Objective: To examine the prevalence of fear of progression (FoP) in Parkinson's disease (PD) patients, and to analyze which sociodemographic, clinical and neuropsychological factors are…Profiling Atypical Anxiety in Parkinson’s Disease
Objective: We aimed to identify the demographic, psychiatric, clinical and cognitive characteristics associated with Anxiety not otherwise specified (NOS) in persons with Parkinson’s disease (PWP).…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.